Synklino
Synklino is an immunotoxin drug for cytomegalovirus in transplant recipients founded in 2017 by Thomas Kledal Ph.D., MBA , Mads Jeppesen Ph.D. and Mette Rosenkilde MD, Ph.D. .
B2X
Business Model
Commerce
Country
Crunchbase URL
Email Address
info@synklino.com
0
Founded Date
2017
Full Address
Rådhusvej 13 2920 Charlottenlund Denmark
0
Investors
Latest Funding Round Date
June 9, 2022
Latest Funding Round Amount (USD)
31,700,000
Latest Funding Type
LinkedIn URL
Phone Number
+4520121656
0
Pitchbook URL
Total Funding Amount (USD)
79,700,000
Official Website
Find more companies like Synklino
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.